MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 67 filers reported holding MARKER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4,919 | -29.7% | 18,500 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $7,000 | +40.0% | 18,500 | +12.1% | 0.00% | +50.0% |
Q2 2022 | $5,000 | -28.6% | 16,500 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $7,000 | -56.2% | 16,500 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $16,000 | -68.0% | 16,500 | -44.1% | 0.00% | -73.3% |
Q3 2021 | $50,000 | -39.0% | 29,500 | 0.0% | 0.02% | -34.8% |
Q2 2021 | $82,000 | +9.3% | 29,500 | -11.9% | 0.02% | 0.0% |
Q1 2021 | $75,000 | +53.1% | 33,500 | 0.0% | 0.02% | +53.3% |
Q4 2020 | $49,000 | -36.4% | 33,500 | -10.7% | 0.02% | -51.6% |
Q2 2020 | $77,000 | +8.5% | 37,500 | 0.0% | 0.03% | -32.6% |
Q1 2020 | $71,000 | -34.3% | 37,500 | -0.4% | 0.05% | +4.5% |
Q4 2019 | $108,000 | -54.0% | 37,650 | -18.2% | 0.04% | -63.3% |
Q3 2019 | $235,000 | -35.4% | 46,019 | 0.0% | 0.12% | -40.9% |
Q2 2019 | $364,000 | +20.1% | 46,019 | +0.2% | 0.20% | -1.5% |
Q1 2019 | $303,000 | +100.7% | 45,919 | +68.4% | 0.21% | +87.3% |
Q4 2018 | $151,000 | – | 27,269 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 2,000,000 | $10,220,000 | 5.33% |
NEA Management Company, LLC | 5,000,000 | $25,550,000 | 2.12% |
One68 Global Capital, LLC | 30,000 | $153,000 | 0.35% |
Perceptive Advisors | 2,000,000 | $10,220,000 | 0.28% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 100,000 | $511,000 | 0.18% |
Quad Capital Management Advisors LLC | 58,232 | $298,000 | 0.15% |
Riggs Asset Managment Co. Inc. | 46,019 | $235,000 | 0.12% |
Baker Brothers Advisors | 1,500,000 | $7,665,000 | 0.05% |
FNY Investment Advisers, LLC | 32,058 | $163,000 | 0.05% |
WEDBUSH SECURITIES INC | 56,568 | $289,000 | 0.03% |